INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Follow-Up Questions
¿Quién es el CEO de INVO Fertility Inc?
Mr. Steven Shum es el Chief Executive Officer de INVO Fertility Inc, se unió a la empresa desde 2017.
¿Qué tal es el rendimiento del precio de la acción IVF?
El precio actual de IVF es de $0.8714, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de INVO Fertility Inc?
INVO Fertility Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de INVO Fertility Inc?
La capitalización bursátil actual de INVO Fertility Inc es $3.7M
¿Es INVO Fertility Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 2 analistas han realizado calificaciones de análisis para INVO Fertility Inc, incluyendo 1 fuerte compra, 3 compra, 1 mantener, 0 venta, y 1 fuerte venta
